Physician profile
Eric S Hazelrigg
NPI 1548249766
$3,989.51
in general payments reported to CMS, 2019-2025
41 companies · $222 in 2025
The $222 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $522 · 2021: $742 · 2022: $882 · 2023: $729 · 2024: $305 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,256.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $765.69 | 2019-2024 | |
| Hologic Sales and Service, LLC | $532.28 | 2019-2024 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Sumitomo Pharma America, INC. | $351.55 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $287.94 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $217.73 | 2021-2025 | |
| Evofem Biosciences, INC. | $187.88 | 2020-2022 | |
| Channel Medsystems, INC. | $143.03 | 2021-2022 | |
| Therapeuticsmd, INC. | $121.37 | 2019-2021 | |
| Exeltis, USA INC. | $112.21 | 2019-2022 | |
| Gynesonics, INC. | $106.09 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Organon LLC | $105.62 | 2021-2024 | |
| Millicent US INC | $99.75 | 2019-2023 | Intrarosa, Femring |
| Daiichi Sankyo INC. | $96.89 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.84 | 2022-2025 | |
| Agile Therapeutics, INC. | $69.02 | 2021 |
Show all 40 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Hazelrigg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.